168 related articles for article (PubMed ID: 9301685)
1. Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. implications for bone marrow purging.
Lydaki E; Dimitriou H; Papazoglou T; Liu WQ; Kalmanti M
Leuk Res; 1997 Jul; 21(7):641-50. PubMed ID: 9301685
[TBL] [Abstract][Full Text] [Related]
2. Merocyanine 540 mediated photoirradiation of leukemic cells. In vitro inference on cell survival.
Lydaki E; Dimitriou H; Papazoglou T; Bolonaki E; Kalmanti M
J Photochem Photobiol B; 1996 Jan; 32(1-2):27-32. PubMed ID: 8725050
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow purging by photodynamic treatment in children with acute leukemia: cytoprotective action of amifostine.
Danilatou V; Lydaki E; Dimitriou H; Papazoglou T; Kalmanti M
Leuk Res; 2000 May; 24(5):427-35. PubMed ID: 10785265
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Atzpodien J; Gulati SC; Clarkson BD
Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
[TBL] [Abstract][Full Text] [Related]
5. Photoradiation methods for purging autologous bone marrow grafts.
Gulati S; Atzpodien J; Lemoli RM; Shimazaki C; Clarkson B
Prog Clin Biol Res; 1990; 333():87-102. PubMed ID: 2137934
[TBL] [Abstract][Full Text] [Related]
6. Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.
Lemoli RM; Igarashi T; Knizewski M; Acaba L; Richter A; Jain A; Mitchell D; Levy J; Gulati SC
Blood; 1993 Feb; 81(3):793-800. PubMed ID: 8427970
[TBL] [Abstract][Full Text] [Related]
7. Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.
Atzpodien J; Gulati SC; Strife A; Clarkson BD
Blood; 1987 Aug; 70(2):484-9. PubMed ID: 2955818
[TBL] [Abstract][Full Text] [Related]
8. Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation.
Sieber F; Rao S; Rowley SD; Sieber-Blum M
Blood; 1986 Jul; 68(1):32-6. PubMed ID: 3521764
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
11. Elimination of leukemic cells by laser photodynamic therapy.
Gulliya KS; Fay JW; Dowben RM; Berkholder S; Matthews JL
Cancer Chemother Pharmacol; 1988; 22(3):211-4. PubMed ID: 3165726
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
[TBL] [Abstract][Full Text] [Related]
13. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
15. Does Hypericum perforatum L. extract show any specificity as photosensitizer for HL-60 leukemic cells and cord blood hemopoietic progenitors during photodynamic therapy?
Kapsokalyvas D; Dimitriou H; Skalkos D; Konstantoudakis G; Filippidis G; Stiakaki E; Papazoglou T; Kalmanti M
J Photochem Photobiol B; 2005 Sep; 80(3):208-16. PubMed ID: 15979884
[TBL] [Abstract][Full Text] [Related]
16. Dye-mediated photolysis of normal and neoplastic hematopoietic cells.
Sieber F; Stuart RK; Rowley SD; Sharkis SJ; Sensenbrenner LL
Leuk Res; 1987; 11(1):43-9. PubMed ID: 3807420
[TBL] [Abstract][Full Text] [Related]
17. Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging.
Gulliya KS; Pervaiz S
Blood; 1989 Mar; 73(4):1059-65. PubMed ID: 2920207
[TBL] [Abstract][Full Text] [Related]
18. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
19. Increased survival of normal cells during laser photodynamic therapy: implications for ex vivo autologous bone marrow purging.
Gulliya KS; Matthews JL; Fay JW; Dowben RM
Life Sci; 1988; 42(25):2651-6. PubMed ID: 3386404
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
